查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1713320

2025年全球植入式输液帮浦市场报告

Implantable Infusion Pumps Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年植入式输液帮浦市场规模将强劲成长。到 2029 年，这一数字将成长至 268.9 亿美元，年复合成长率(CAGR)为 7.0%。预测期内的成长归因于个人化医疗、远端患者监护、药物开发和慢性病管理。预测期内的关键趋势包括微创植入、远端监控和程式设计、鞘内疼痛管理和多学科合作。

慢性疼痛、癌症和糖尿病等慢性疾病的盛行率不断上升预计将推动对植入式输液帮浦的需求。通常使用帮浦来注射药物来治疗这些疾病。由于人口老化和生活方式的改变，全球慢性疾病和残疾的逐渐增加凸显了对此类医疗设备的需求。例如，根据美国癌症协会2022年1月发布的报告，预计2022年美国将新增190万例癌症病例，609,360例癌症死亡病例。此外，估计还有10,470名儿童和5,480名青少年罹患癌症。预计此类慢性疾病的增加将对植入式输液帮浦市场的成长做出重大贡献。

预计老龄人口的不断增加将进一步推动植入式输液帮浦市场的成长。植入式输液帮浦广泛用于治疗慢性疾病，因此对于能够从这些设备中受益的日益增长的老龄化人口来说至关重要。根据世界卫生组织（WHO）2022年10月发布的报告，预计到2030年，全球六分之一的人口将超过60岁，预计2020年至2050年间80岁及以上人口将增加4.26亿。预测到2050年，全球将有21亿人年龄在60岁或以上，预计人口老化将持续推动植入式输注帮浦的需求。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球植入式输液帮浦 PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球植入式输液帮浦市场：成长率分析
  • 全球植入式输液帮浦市场表现：规模与成长，2019-2024
  • 全球植入式输液帮浦市场预测：规模与成长，2024-2029 年，2034 年
  • 植入式输液帮浦的全球总目标市场（TAM）

第六章市场区隔

  • 全球植入式输液帮浦市场：按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 病人自控镇痛（PCA）泵
  • 肠内泵
  • 胰岛素帮浦
  • 弹性体泵
  • 注射式帮浦
  • 其他类型
  • 全球植入式输液帮浦市场：按应用、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 肿瘤学
  • 小儿科或新生儿科
  • 胃肠病学
  • 血液学
  • 糖尿病
  • 其他用途
  • 全球植入式输液帮浦市场：依最终用户、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 门诊手术中心
  • 专科诊所
  • 全球植入式输液帮浦市场依病患自控镇痛 (PCA) 帮浦类型细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 氢可酮PCA泵
  • FentanylPCA泵
  • 其他阿片类药物PCA泵
  • 全球植入式输液帮浦市场细分（按肠内帮浦类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 管饲帮浦
  • 基于注射器的肠内泵
  • 定期或间歇供水泵
  • 全球植入式输液帮浦市场细分（按胰岛素帮浦类型、效能和预测），2019-2024 年、2024-2029 年、2034 年
  • 胰岛素输注泵
  • 胰岛素贴片帮浦
  • 智慧胰岛素泵
  • 全球植入式输液帮浦市场细分（按弹性帮浦类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 一次性弹性体泵
  • 可重复使用的弹性体泵
  • 全球植入式输液帮浦市场细分（按註射注射式帮浦类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 小容量注射式帮浦
  • 大容量注射式帮浦
  • 全球植入式输液帮浦市场，按类型细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 化疗输液泵
  • 抗生素输液泵
  • 疼痛管理泵

第七章 区域和国家分析

  • 全球植入式输液帮浦市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球植入式输液帮浦市场：依国家、地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 植入式输液帮浦市场：竞争格局
  • 植入式输液帮浦市场：公司简介
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Nevro Corp Overview, Products and Services, Strategy and Financial Analysis
    • LivaNova PLC Overview, Products and Services, Strategy and Financial Analysis
    • Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • B. Braun Melsungen AG
  • Fresenius Kabi AG
  • Smiths Medical, a Smiths Group company
  • Terumo Corporation
  • Johnson & Johnson
  • Greatbatch Medical
  • NeuroPace Inc.
  • Primetech Corporation
  • Flowonix Medical Inc.
  • F. Hoffmann-La Roche Ltd
  • Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
  • Micrel Medical
  • Insulet Corporation
  • ICU Medical Inc.
  • Becton Dickinson and Company（BD）

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029年植入式输液帮浦市场：提供新机会的国家
  • 2029年植入式输液帮浦市场：细分市场带来新机会
  • 2029年植入式输液帮浦市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r32598

Implantable infusion pumps are advanced drug delivery systems designed to be surgically implanted within a patient's body. These devices are responsible for controlled and precise administration of medication directly into the bloodstream.

The implantable infusion pumps market is categorized into several types, including patient-controlled analgesia (PCA) pumps, enteral pumps, insulin pumps, elastomeric pumps, syringe pumps, and other variations. For instance, insulin pumps are small devices implanted under the skin during surgical procedures to continuously deliver insulin for patients with diabetes. These implantable infusion pumps find applications across various medical fields, including oncology, pediatrics/neonatology, gastroenterology, hematology, diabetes, and more. They are commonly used in healthcare settings such as hospitals, ambulatory surgical centers, and specialty clinics to provide effective and precise drug delivery to patients.

The implantable infusion pumps market research report is one of a series of new reports from The Business Research Company that provides implantable infusion pumps market statistics, including implantable infusion pumps industry global market size, regional shares, competitors with a implantable infusion pumps market share, detailed implantable infusion pumps market segments, market trends and opportunities, and any further data you may need to thrive in the implantable infusion pumps industry. This implantable infusion pumps market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The implantable infusion pumps market size has grown steadily in recent years. It will grow from $19.59 billion in 2024 to $20.48 billion in 2025 at a compound annual growth rate (CAGR) of 4.6%. The growth in the historic period can be attributed to chronic disease management, aging population, pain management, regulatory approvals.

The implantable infusion pumps market size is expected to see strong growth in the next few years. It will grow to $26.89 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to personalized medicine, remote patient monitoring, drug development, chronic disease management. Major trends in the forecast period include minimally invasive implantation, remote monitoring and programming, intrathecal pain management, interdisciplinary collaboration.

The escalating prevalence of chronic conditions such as chronic pain, cancer, and diabetes is anticipated to be a driving force behind the demand for implantable infusion pumps. These pumps are commonly utilized to administer pharmaceutical drugs for treating these ailments. The gradual increase in chronic illnesses and disorders worldwide, primarily attributed to an aging population and shifts in lifestyle, underscores the need for such medical devices. For example, a report published by the American Cancer Society in January 2022 highlighted an anticipated 1.9 million new cancer cases in the US in 2022, with 609,360 projected deaths. An estimated 10,470 pediatric cancer cases and 5,480 teenage cancer diagnoses are also expected. This rise in chronic diseases is projected to significantly contribute to the growth of the implantable infusion pumps market.

The expanding aging population is predicted to further fuel the growth of the implantable infusion pumps market. Implantable infusion pumps are extensively used in the management of chronic conditions, making them crucial for a growing aging demographic that can benefit from these devices. A report by the World Health Organization (WHO) in October 2022 revealed that by 2030, one in six individuals globally will be 60 or older, while the number of individuals aged 80 or older is estimated to increase by 426 million between 2020 and 2050. With projections indicating 2.1 billion people worldwide aged 60 or older by 2050, the rising aging population will continue to drive the demand for implantable infusion pumps.

Market players in the implantable infusion pump industry are increasingly prioritizing the development of smart infusion pumps. The utilization of wireless technology in healthcare monitoring devices is on the rise, providing improved ease of use, connectivity, and data analysis. Integrating wireless technology allows seamless data transfer from the device to a smartphone or another wireless device using Bluetooth or cellular connections. This facilitates data processing, display, and subsequent analysis for studying the individual's health condition. Moreover, software platforms are being innovated to enable patient monitoring and reduce the occurrence of human error in the process.

Leading companies in the implantable infusion pump market are focusing on the development of new products, such as insulin pumps, to address a broader customer base, boost sales, and increase revenue. Insulin pumps are medical devices designed to assist individuals with diabetes in managing their blood sugar levels. Notably, in April 2023, Medtronic, an Ireland-based medical device company, announced the FDA approval for the MiniMed 780G System featuring meal detection technology. This product distinguishes itself by setting the lowest glucose target (as low as 100 mg/dL) among all automated insulin pumps available in the market, aiming to closely mirror the average glucose levels of individuals without diabetes. The system operates on a treat-to-target basis, automatically making basal insulin adjustments and autocorrections to attain a specific target. Additionally, it stands out as the only pump featuring an infusion set that can be worn comfortably for an extended period of up to 7 days. This extended wear time is facilitated by advanced materials that minimize insulin preservative loss, maintaining consistent insulin flow and stability while reducing the likelihood of infusion set occlusion.

In March 2022, Vygon SAS, a Paris-based manufacturer of medical devices and healthcare solutions, acquired Macatt Medica Peruana SAC for an undisclosed amount. The acquisition aims to bolster Vygon's product portfolio, expand its market reach, integrate innovative technologies, and enhance its competitive position. Macatt Medica Peruana SAC, a Peru-based company, specializes in the development and production of advanced medical devices, with a particular focus on infusion systems for direct medication delivery.

Major companies operating in the implantable infusion pumps market include Medtronic PLC, Boston Scientific Corporation, Nevro Corp, LivaNova PLC, Baxter International Inc., B. Braun Melsungen AG, Fresenius Kabi AG, Smiths Medical a Smiths Group company, Terumo Corporation, Johnson & Johnson, Greatbatch Medical, NeuroPace Inc., Primetech Corporation, Flowonix Medical Inc., F. Hoffmann-La Roche Ltd, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Micrel Medical, Insulet Corporation, ICU Medical Inc., Becton Dickinson and Company (BD), Roche Diagnostics International AG, Abbott Laboratories, Hospira, Stryker Corporation, Zimmer Biomet Holdings Inc., Teleflex Incorporated, C. R. Bard Inc., AngioDynamics Inc., Merit Medical Systems Inc., NIPRO Medical Corporation, IRadimed Corporation, Zyno Medical, Tricumed Medizintechnik GmbH, Q Core Medical Ltd., Ivenix Inc., Tandem Diabetes Care Inc.

North America was the largest region in the implantable infusion pumps market in 2024. Asia-Pacific was the second-largest region in the implantable infusion pumps market. The regions covered in the implantable infusion pumps market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the implantable infusion pumps market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The implantable infusion pumps market consists of sales of instruments such as patient-controlled analgesia (PCA) pumps, enteral pumps, insulin pumps, elastomeric pumps, syringe pumps, and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Implantable Infusion Pumps Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on implantable infusion pumps market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for implantable infusion pumps ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The implantable infusion pumps market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Patient-Controlled Analgesia (PCA) Pumps; Enteral Pumps; Insulin Pumps; Elastomeric Pumps; Syringe Pumps; Other Types
  • 2) By Applications: Oncology; Pediatrics Or Neonatology; Gastroenterology; Hematology; Diabetes; Other Applications
  • 3) By End User: Hospitals; Ambulatory Surgical Centers; Specialty Clinics
  • Subsegments:
  • 1) By Patient-Controlled Analgesia (PCA) Pumps: Morphine PCA Pumps; Fentanyl PCA Pumps; Other Opioid PCA Pumps
  • 2) By Enteral Pumps: Tube Feeding Pumps; Syringe-based Enteral Pumps; Continuous Or Intermittent Feeding Pumps
  • 3) By Insulin Pumps: Insulin Delivery Pumps; Insulin Patch Pumps; Smart Insulin Pumps
  • 4) By Elastomeric Pumps: Disposable Elastomeric Pumps; Reusable Elastomeric Pumps
  • 5) By Syringe Pumps: Small Volume Syringe Pumps; Large Volume Syringe Pumps
  • 6) By Other Types: Chemotherapy Infusion Pumps; Antibiotic Infusion Pumps; Pain Management Pumps
  • Companies Mentioned: Medtronic plc; Boston Scientific Corporation; Nevro Corp; LivaNova PLC; Baxter International Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Implantable Infusion Pumps Market Characteristics

3. Implantable Infusion Pumps Market Trends And Strategies

4. Implantable Infusion Pumps Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Implantable Infusion Pumps Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Implantable Infusion Pumps PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Implantable Infusion Pumps Market Growth Rate Analysis
  • 5.4. Global Implantable Infusion Pumps Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Implantable Infusion Pumps Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Implantable Infusion Pumps Total Addressable Market (TAM)

6. Implantable Infusion Pumps Market Segmentation

  • 6.1. Global Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Patient-Controlled Analgesia (PCA) Pumps
  • Enteral Pumps
  • Insulin Pumps
  • Elastomeric Pumps
  • Syringe Pumps
  • Other Types
  • 6.2. Global Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oncology
  • Pediatrics Or Neonatology
  • Gastroenterology
  • Hematology
  • Diabetes
  • Other Applications
  • 6.3. Global Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • 6.4. Global Implantable Infusion Pumps Market, Sub-Segmentation Of Patient-Controlled Analgesia (PCA) Pumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Morphine PCA Pumps
  • Fentanyl PCA Pumps
  • Other Opioid PCA Pumps
  • 6.5. Global Implantable Infusion Pumps Market, Sub-Segmentation Of Enteral Pumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tube Feeding Pumps
  • Syringe-based Enteral Pumps
  • Continuous or Intermittent Feeding Pumps
  • 6.6. Global Implantable Infusion Pumps Market, Sub-Segmentation Of Insulin Pumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Insulin Delivery Pumps
  • Insulin Patch Pumps
  • Smart Insulin Pumps
  • 6.7. Global Implantable Infusion Pumps Market, Sub-Segmentation Of Elastomeric Pumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Disposable Elastomeric Pumps
  • Reusable Elastomeric Pumps
  • 6.8. Global Implantable Infusion Pumps Market, Sub-Segmentation Of Syringe Pumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Small Volume Syringe Pumps
  • Large Volume Syringe Pumps
  • 6.9. Global Implantable Infusion Pumps Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Chemotherapy Infusion Pumps
  • Antibiotic Infusion Pumps
  • Pain Management Pumps

7. Implantable Infusion Pumps Market Regional And Country Analysis

  • 7.1. Global Implantable Infusion Pumps Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Implantable Infusion Pumps Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Implantable Infusion Pumps Market

  • 8.1. Asia-Pacific Implantable Infusion Pumps Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Implantable Infusion Pumps Market

  • 9.1. China Implantable Infusion Pumps Market Overview
  • 9.2. China Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Implantable Infusion Pumps Market

  • 10.1. India Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Implantable Infusion Pumps Market

  • 11.1. Japan Implantable Infusion Pumps Market Overview
  • 11.2. Japan Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Implantable Infusion Pumps Market

  • 12.1. Australia Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Implantable Infusion Pumps Market

  • 13.1. Indonesia Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Implantable Infusion Pumps Market

  • 14.1. South Korea Implantable Infusion Pumps Market Overview
  • 14.2. South Korea Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Implantable Infusion Pumps Market

  • 15.1. Western Europe Implantable Infusion Pumps Market Overview
  • 15.2. Western Europe Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Implantable Infusion Pumps Market

  • 16.1. UK Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Implantable Infusion Pumps Market

  • 17.1. Germany Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Implantable Infusion Pumps Market

  • 18.1. France Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Implantable Infusion Pumps Market

  • 19.1. Italy Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Implantable Infusion Pumps Market

  • 20.1. Spain Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Implantable Infusion Pumps Market

  • 21.1. Eastern Europe Implantable Infusion Pumps Market Overview
  • 21.2. Eastern Europe Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Implantable Infusion Pumps Market

  • 22.1. Russia Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Implantable Infusion Pumps Market

  • 23.1. North America Implantable Infusion Pumps Market Overview
  • 23.2. North America Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Implantable Infusion Pumps Market

  • 24.1. USA Implantable Infusion Pumps Market Overview
  • 24.2. USA Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Implantable Infusion Pumps Market

  • 25.1. Canada Implantable Infusion Pumps Market Overview
  • 25.2. Canada Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Implantable Infusion Pumps Market

  • 26.1. South America Implantable Infusion Pumps Market Overview
  • 26.2. South America Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Implantable Infusion Pumps Market

  • 27.1. Brazil Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Implantable Infusion Pumps Market

  • 28.1. Middle East Implantable Infusion Pumps Market Overview
  • 28.2. Middle East Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Implantable Infusion Pumps Market

  • 29.1. Africa Implantable Infusion Pumps Market Overview
  • 29.2. Africa Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Implantable Infusion Pumps Market Competitive Landscape And Company Profiles

  • 30.1. Implantable Infusion Pumps Market Competitive Landscape
  • 30.2. Implantable Infusion Pumps Market Company Profiles
    • 30.2.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Nevro Corp Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. LivaNova PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Implantable Infusion Pumps Market Other Major And Innovative Companies

  • 31.1. B. Braun Melsungen AG
  • 31.2. Fresenius Kabi AG
  • 31.3. Smiths Medical, a Smiths Group company
  • 31.4. Terumo Corporation
  • 31.5. Johnson & Johnson
  • 31.6. Greatbatch Medical
  • 31.7. NeuroPace Inc.
  • 31.8. Primetech Corporation
  • 31.9. Flowonix Medical Inc.
  • 31.10. F. Hoffmann-La Roche Ltd
  • 31.11. Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
  • 31.12. Micrel Medical
  • 31.13. Insulet Corporation
  • 31.14. ICU Medical Inc.
  • 31.15. Becton Dickinson and Company (BD)

32. Global Implantable Infusion Pumps Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Implantable Infusion Pumps Market

34. Recent Developments In The Implantable Infusion Pumps Market

35. Implantable Infusion Pumps Market High Potential Countries, Segments and Strategies

  • 35.1 Implantable Infusion Pumps Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Implantable Infusion Pumps Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Implantable Infusion Pumps Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer